AVANT BIO (Fund II) Invests in Nomic Bio, PathPresenter and PL BioScience

Pamlico Capital Announces Strategic Growth Investment in AVANT

October 22, 2021

IT Services

Pamlico Capital provided a strategic growth investment in AVANT to accelerate the Chicago-based IT distributor's expansion and scale its platform for IT decision-making. AVANT's founders and management retain significant ownership and will continue to run the business as the company grows hiring and expands capabilities across cloud, security and UCaaS offerings.

Court Square and Pamlico Capital Invest in AVANT

December 17, 2025

IT Services

AVANT, a Chicago-based technology services distributor and sales-enablement platform for Trusted Advisors, received a strategic growth investment from Court Square Capital Partners with a reinvestment from existing partner Pamlico Capital. The founders and executive leadership retain significant ownership and will continue to run the business as the new capital will be used to scale AVANT's platform, capabilities, and support continued growth initiatives.

StageBio Acquires TPL Path Labs

October 21, 2020

Healthcare Services

StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.

IK Partners Acquires Majority Stake in BIOBank

May 29, 2024

Medical Devices

IK Partners (via its IK Small Cap III fund) has agreed to acquire a majority stake in French tissue bank BIOBank from Verto Growth, Capital Croissance and management, who will reinvest. BIOBank, headquartered in Lieusaint, France, is a leading processor and distributor of bone allografts for orthopaedic, spine, dental and cranio‑maxillofacial surgery; IK plans to support market-share gains in France, accelerate international expansion and pursue a buy‑and‑build strategy.

Ampersand Capital Partners Invests in iuvo BioScience

September 28, 2022

Healthcare Services

Ampersand Capital Partners has agreed to acquire a stake in iuvo BioScience, a Rochester-based specialty CRO that provides laboratory, preclinical, clinical development, and scientific consulting services. The investment will fund expansion of iuvo's integrated service portfolio and laboratory capacity and support an active inorganic (add-on) growth strategy; founders Ben Burton and Mary Richardson will remain in leadership roles and as shareholders.

Avista Capital Partners Invests in eMolecules

March 25, 2021

Healthcare Services

Avista Capital Partners has signed a definitive agreement to invest in eMolecules, a San Diego–based e-procurement and marketplace platform for high-value chemicals and bioreagents used in drug discovery. Financial terms were not disclosed; Avista said the investment will support eMolecules' growth and expansion into additional biopharma and academic customers.